The new insulin, Awiqli, is cheaper than many daily insulin analogues and could ease fears of multiple injections among ...
Designed to reduce daily insulin injections to a single weekly dose, the long-acting insulin aims to improve treatment ...
Novo Nordisk India launched Awiqli, the first once-weekly basal insulin for diabetes, reducing injections from daily to ...
Awiqli, the world's first weekly insulin, simplifies diabetes management by reducing daily injections while improving ...
India Today on MSN
World's first and only once-weekly insulin launched in India
Novo Nordisk has launched Awiqli, the world's first once-weekly basal insulin, in India. The therapy is aimed at easing ...
The MarketWatch News Department was not involved in the creation of this content. -- Awiqli(R) (insulin icodec-abae) injection is the first-ever once-weekly basal insulin approved by the FDA1 -- ...
Novo Nordisk is set to introduce Awiqli, an innovative once-weekly insulin, in India shortly. This remarkable treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results